Home
english
2024
09
23
Vicebio secures $100m to advance RSV and hMPV vaccine combo to Phase I - Clinical Trials Arena
Date:
2024-09-23 07:00
Original URL:
https://news.google.com/rss/articles/CBMisAFBVV95cUxQQTAtbEJWOXBkRnlHdy1xVTlLYV9MajJuMEt5Z19pWnI0MXZUTWV3cW9QaHliZkZwODJfeDcxemVCVGJwVVdmUF9OUzBmUTJsSno1UDdpQXhfVDB3MWs4MzVyeDRTZlFwZVBob085M2ppN3dPcGxCaXpKcEhDYWp1UHNhTGMxTVpvbDBlcTVlZHRuMnBiaEJHQk1nNkZ5Qk5HMVpYTnZrZFI4UnlLRVA2dQ?oc=5